Found: 9
Select item for more details and to access through your institution.
Interim phase 1 part A results for ALN‐APP, the first investigational RNAi therapeutic in development for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082650
- By:
- Publication type:
- Article
Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. e46, doi. 10.1111/bjh.18274
- By:
- Publication type:
- Article
Efficacy and safety of the C5 inhibitor crovalimab in complement inhibitor‐naive patients with PNH (COMMODORE 3): A multicenter, Phase 3, single‐arm study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. 1407, doi. 10.1002/ajh.26998
- By:
- Publication type:
- Article
Tumor Static Concentration Curves in Combination Therapy.
- Published in:
- AAPS Journal, 2017, v. 19, n. 2, p. 456, doi. 10.1208/s12248-016-9991-1
- By:
- Publication type:
- Article
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 300, doi. 10.1111/ejh.14011
- By:
- Publication type:
- Article
Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab.
- Published in:
- Clinical Medicine Insights: Oncology, 2019, v. 13, p. N.PAG, doi. 10.1177/1179554919852071
- By:
- Publication type:
- Article
Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab.
- Published in:
- Clinical Medicine Insights: Oncology, 2019, v. 13, p. N.PAG, doi. 10.1177/1179554919852071
- By:
- Publication type:
- Article
Quantitative evaluation of the combination between cytotoxic drug and efflux transporter inhibitors based on a tumour growth inhibition model.
- Published in:
- Fundamental & Clinical Pharmacology, 2014, v. 28, n. 2, p. 161, doi. 10.1111/fcp.12005
- By:
- Publication type:
- Article
A template model for studying anticancer drug efflux transporter inhibitors in vitro.
- Published in:
- Fundamental & Clinical Pharmacology, 2013, v. 27, n. 5, p. 544, doi. 10.1111/j.1472-8206.2012.01054.x
- By:
- Publication type:
- Article